Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lymphangioleiomyoma of the Uterus and Pelvic Lymph Nodes: A Report of 3 Cases, Including the Potentially Earliest Manifestation of Extrapulmonary Lymphangioleiomyomatosis.
Ando H, Ogawa M, Watanabe Y, Tsurunaga K, Nakamura C, Tamura H, Ikeda K, Takahashi R, Nakajima R, Yoshida S, Tsujie T, Doi R, Wakimoto A, Adachi S. Ando H, et al. Among authors: wakimoto a. Int J Gynecol Pathol. 2020 May;39(3):227-232. doi: 10.1097/PGP.0000000000000589. Int J Gynecol Pathol. 2020. PMID: 30789500
Postoperative administration of dienogest for suppressing recurrence of disease and relieving pain in subjects with ovarian endometriomas.
Adachi K, Takahashi K, Nakamura K, Otake A, Sasamoto N, Miyoshi Y, Shioji M, Yamamoto Y, Fujitani M, Wakimoto A, Tokuhira A, Kobayashi E, Yoshimura A, Sawada K, Kimura T. Adachi K, et al. Among authors: wakimoto a. Gynecol Endocrinol. 2016 Aug;32(8):646-649. doi: 10.3109/09513590.2016.1147547. Epub 2016 Feb 18. Gynecol Endocrinol. 2016. PMID: 26890948
Combination chemotherapy with irinotecan and gemcitabine for taxane/platinum-resistant/refractory ovarian and primary peritoneal cancer: a multicenter phase I/II trial (GOGO-Ov 6).
Yoshino K, Kamiura S, Yokoi T, Nakae R, Fujita M, Takemura M, Adachi K, Wakimoto A, Nishizaki T, Shiki Y, Tsutsui T, Kanda Y, Kobayashi E, Hashimoto K, Mabuchi S, Ueda Y, Sawada K, Tomimatsu T, Kimura T. Yoshino K, et al. Among authors: wakimoto a. Cancer Chemother Pharmacol. 2017 Dec;80(6):1239-1247. doi: 10.1007/s00280-017-3468-5. Epub 2017 Oct 28. Cancer Chemother Pharmacol. 2017. PMID: 29080971 Clinical Trial.
Chemotherapy for endometrial carcinoma (GOGO-EM1 study): TEC (paclitaxel, epirubicin, and carboplatin) is an effective remission-induction and adjuvant therapy.
Egawa-Takata T, Ueda Y, Kuragaki C, Miyake T, Miyatake T, Fujita M, Yoshino K, Nakashima R, Okazawa M, Tsutsui T, Morishige K, Kimura T, Yamasaki M, Nishizaki T, Nagamatsu M, Ito K, Asada M, Ogita K, Wakimoto A, Yamamoto T, Nishio Y, Enomoto T. Egawa-Takata T, et al. Among authors: wakimoto a. Cancer Chemother Pharmacol. 2011 Dec;68(6):1603-10. doi: 10.1007/s00280-011-1638-4. Epub 2011 May 17. Cancer Chemother Pharmacol. 2011. PMID: 21584840 Clinical Trial.
Prognostic significance of p53 mutation in suboptimally resected advanced ovarian carcinoma treated with the combination chemotherapy of paclitaxel and carboplatin.
Ueno Y, Enomoto T, Otsuki Y, Sugita N, Nakashima R, Yoshino K, Kuragaki C, Ueda Y, Aki T, Ikegami H, Yamazaki M, Ito K, Nagamatsu M, Nishizaki T, Asada M, Kameda T, Wakimoto A, Mizutani T, Yamada T, Murata Y. Ueno Y, et al. Among authors: wakimoto a. Cancer Lett. 2006 Sep 28;241(2):289-300. doi: 10.1016/j.canlet.2005.10.035. Epub 2006 Feb 3. Cancer Lett. 2006. PMID: 16459017
Selection of acrosome-reacted sperm with MH61-immunobeads.
Ohashi K, Saji F, Wakimoto A, Tsutsui T, Nakazawa T, Okabe M, Mimura T, Tanizawa O. Ohashi K, et al. Among authors: wakimoto a. J Androl. 1994 Jan-Feb;15(1):78-82. J Androl. 1994. PMID: 8188539 Free article.
23 results